Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 04, 2021

SELL
$478.3 - $607.98 $345,332 - $438,961
-722 Closed
0 $0
Q1 2020

Apr 30, 2020

SELL
$336.18 - $494.43 $243,058 - $357,472
-723 Reduced 50.03%
722 $353,000
Q3 2019

Nov 08, 2019

BUY
$273.46 - $318.39 $190,054 - $221,281
695 Added 92.67%
1,445 $401,000
Q1 2019

May 15, 2019

BUY
$372.08 - $439.57 $42,789 - $50,550
115 Added 18.11%
750 $308,000
Q4 2018

Feb 12, 2019

BUY
$335.82 - $403.04 $213,245 - $255,930
635 New
635 $237,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.8B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Community Capital Management, LLC Portfolio

Follow Community Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Community Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Community Capital Management, LLC with notifications on news.